subject: Telcagepant - The Miracle Migraine Headache Relief - Why You Have Not Gotten It Yet? [print this page] Telcagepant - The Miracle Migraine Headache Relief - Why You Have Not Gotten It Yet?
If you are a migraine sufferer, searching for the miracle migraine headache relief, you are going to be ecstatic to hear this. There is a new medication that should give you the lasting relief that you have been so desperately looking for. The question is not if the drug exists, it is when it will become available to you. Discovered in 1984 by professor Lars Edvinson at the University Hospital in Lund, South Sweden, a peptide called CGRP has the potential to change many lives. Originally, this drug was going to be released this year, so why has this not happened yet?
In the past two years, marketing for Telcagepant began. Advertisements about this powerful new medication were posted on the internet and printed in magazine spreads. Why is everyone so excited about this drug when there are so many other migraine pills on the market today? Telcagepant offers the added promise of no side effects for its patients. However, with the continued delay in this product hitting the market, it is causing migraine patients to lose their hope for this "miracle drug".
In recent events, the American drug company Merck, who developed this medication, decided to stop the introduction of Telcagepant. Then it was quickly understood that it was actually the FDA, Food and Drug Administration, in the USA that did not want this drug approved. Another turn of events came when it was discovered that Merck themselves had actually stopped the pill being introduced on the market, and Merck also informed the FDA of their decision. So as a migraine sufferer, what are you possibly supposed to do now? Any hope, of this migraine headache relief, has been dashed, and many people now feel like they are back at square one.
Another bit of information came when it started being rumored that the medicine actually did contain side effects, in fact quite a few side effects. It has been suggested that the presence of these side effects combined with the potential damage to the liver is what has halted the release of the drug. Fatigue, dizziness, nausea, and dry mouth are the complaints that have been made.
Currently, Telcagepant should be released in autumn of 2011. Despite the numerous problems, for this new migraine headache relief, involving the side effects and possible liver problems, the FDA is allowing Merck one more year to get everything under control so that the drug can be safe for migraine patients. While there is still hope for migraine sufferers, one could question just how much longer patients will be able to hold out hope.
